383 related articles for article (PubMed ID: 27342213)
1. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
Lunder AK; Hov JR; Borthne A; Gleditsch J; Johannesen G; Tveit K; Viktil E; Henriksen M; Hovde Ø; Huppertz-Hauss G; Høie O; Høivik ML; Monstad I; Solberg IC; Jahnsen J; Karlsen TH; Moum B; Vatn M; Negård A
Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
[TBL] [Abstract][Full Text] [Related]
2. Investigative MRI cholangiopancreatography for primary sclerosing cholangitis-type lesions in children with IBD.
Alexopoulou E; Xenophontos PE; Economopoulos N; Spyridopoulos TN; Papakonstantinou O; Panayotou I; Dimakou K; Roma E; Kelekis NL
J Pediatr Gastroenterol Nutr; 2012 Sep; 55(3):308-13. PubMed ID: 22569526
[TBL] [Abstract][Full Text] [Related]
3. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.
Belle A; Laurent V; Pouillon L; Baumann C; Orry X; Lopez A; Rousseau H; Bronowicki JP; Peyrin-Biroulet L
Dig Liver Dis; 2018 Oct; 50(10):1012-1018. PubMed ID: 30076016
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
Hadizadeh M; Abedi SH; Malekpour H; Radinnia E; Jabbehdari S; Padashi M; Zali MR; Mohammad Alizadeh AH
Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
[TBL] [Abstract][Full Text] [Related]
6. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
7. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
8. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
Rocha HC; Vilela EG
Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
[TBL] [Abstract][Full Text] [Related]
14. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
[TBL] [Abstract][Full Text] [Related]
17. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
20. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Broomé U; Löfberg R; Lundqvist K; Veress B
Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]